Optimizing the Filtration of Liposomes Using Sterilizing-Grade Filters

References

1. 1.↵
   1. Chang H.-I.,
   2. Yeh M.-K.

   Clinical Development of Liposome-Based Drugs: Formulation, Characterization, and Therapeutic Efficacy. Int J Nanomed. 2012, 7, 49–60.

   OpenUrlWeb of Science
2. 2.↵
   1. Allen T. M.,
   2. Cullis P.

   Liposomal Drug Delivery Systems: From Concept to Clinical Applications. Adv. Drug Delivery Rev 2013, 65 (1), 36–48.

   OpenUrlCrossRefPubMed
3. 3.↵
   1. Carugo D.,
   2. Bottaro E.,
   3. Owen J.,
   4. Stride E.,
   5. Nastruzzi C.

   Liposome Production by Microfluidics: Potential and Limiting Factors. Sci. Rep. 2016, 6 (1), 25876.

   OpenUrlCrossRef
4. 4.↵
   1. Alavi M.,
   2. Karimi N.,
   3. Safaei M.

   Application of Various Types of Liposomes in Drug Delivery Systems. Adv. Pharm. Bull. 2017, 7 (1), 3–9.

   OpenUrl
5. 5.↵
   1. Pattni B. S.,
   2. Chupin V. V.,
   3. Torchilin V. P.

   New Developments in Liposomal Drug Delivery. Chem. Rev. 2015, 115 (19), 10938−10966.

   OpenUrlCrossRefPubMed
6. 6.↵
   1. Bulbake U.,
   2. Doppalapudi S.,
   3. Kommineni N.,
   4. Khan W.

   Liposomal Formulations in Clinical Use: An Updated Review. Pharmaceutics 2017, 9 (2), 12.

   OpenUrlCrossRef
7. 7.↵
   1. Wagner A.,
   2. Vorauer-Uhl K.

   Liposome Technology for Industrial Purposes. J. Drug Delivery 2011, 2011, 591325.
8. 8.↵
   1. Torchilin V. P.

   Recent Advances with Liposomes as Pharmaceutical Carriers. Nat. Rev. Drug Discovery 2005, 4 (2), 145–160.

   OpenUrlCrossRefPubMedWeb of Science
9. 9.↵
   1. Sercombe L.,
   2. Veerati T.,
   3. Moheimani F.,
   4. Wu S. Y.,
   5. Sood A. K.,
   6. Hua S.

   Advances and Challenges of Liposome Assisted Drug Delivery. Front. Pharmacol. 2015, 6, 286.

   OpenUrlCrossRefPubMed
10. 10.↵
    1. Toh M.-R.,
    2. Chiu G. N. C.

    Liposomes as Sterile Preparations and Limitations of Sterilisation Techniques in Liposomal Manufacturing. Asian J. Pharm. Sci. 2013, 8 (2), 88–95.

    OpenUrl
11. 11.↵
    1. Huang Z.,
    2. Li X.,
    3. Zhang T.,
    4. Song Y.,
    5. She Z.,
    6. Li J.,
    7. Deng Y.

    Progress Involving New Techniques for Liposome Preparation. Asian J. Pharm. Sci. 2014, 9 (4), 176–182.

    OpenUrl
12. 12.↵
    1. Jahn A.,
    2. Vreeland W. N.,
    3. DeVoe D. L.,
    4. Locascio L. E.,
    5. Gaitan M.

    Microfluidic Directed Formation of Liposomes of Controlled Size. Langmuir 2007, 23 (11), 6289–6293.

    OpenUrlCrossRefPubMedWeb of Science
13. 13.↵
    1. Patil Y. P.,
    2. Jadhav S.

    Novel Methods for Liposome Preparation. Chem. Phys. Lipids 2014, 177, 8–18.

    OpenUrlCrossRefWeb of Science
14. 14.↵
    1. Franzen U.,
    2. Østergaard J.

    Physico-Chemical Characterization of Liposomes and Drug Substance–Liposome Interactions in Pharmaceutics Using Capillary Electrophoresis and Electrokinetic Chromatography. J. Chromatogr. A 2012, 1267 (7), 32–44.

    OpenUrlPubMed
15. 15.↵
    1. Smith M. C.,
    2. Crist R. M.,
    3. Clogston J. D.,
    4. McNeil S. E.

    Zeta Potential: A Case Study of Cationic, Anionic, and Neutral Liposomes. Anal. Bioanal. Chem. 2017, 409 (24), 5779–5787.

    OpenUrl
16. 16.↵
    1. Nimesh S.,
    2. Chandra R.

    1. Kumar A.,
    2. Dixit C. K.

    Methods for Characterization of Nanoparticles. In Advances in Nanomedicine for the Delivery of Therapeutic Nucleic Acids, Nimesh S., Chandra R., Eds.; Woodhead Publishing, 2017, pp 43–58.
17. 17.↵
    1. Laouini A.,
    2. Jaafar-Maalej C.,
    3. Limayem-Blouza I.,
    4. Sfar S.,
    5. Charcosset C.,
    6. Fessi H.

    Preparation, Characterization and Applications of Liposomes: State of the Art. J. Colloid Sci. Biotechnol. 2012, 1 (2), 147–168.

    OpenUrlCrossRef
18. 18.↵
    1. Willmott G. R.

    Tunable Resistive Pulse Sensing: Better Size and Charge Measurements for Submicrometer Colloids. Anal. Chem. 2018, 90 (5), 2987–2995.

    OpenUrl
19. 19.↵
    1. Duan Y.,
    2. Liu Y.,
    3. Li J.,
    4. Wang H.,
    5. Wen S.

    Investigation on the Nanomechanics of Liposome Adsorption on Titanium Alloys: Temperature and Loading Effects. Polymers 2018, 10 (4), 383.

    OpenUrl
20. 20.↵
    1. Et-Thakafy O.,
    2. Delorme N.,
    3. Gaillard C.,
    4. Mériadec C.,
    5. Artzner F.,
    6. Lopez C.,
    7. Guyomarc’h F.

    Mechanical Properties of Membranes Composed of Gel-Phase or Fluid-Phase Phospholipids Probed on Liposomes by Atomic Force Spectroscopy. Langmuir 2017, 33 (21), 5117–5126.

    OpenUrl
21. 21.↵
    1. Ramachandran S.,
    2. Quist A. P.,
    3. Kumar S.,
    4. Lal R.

    Cisplatin Nanoliposomes for Cancer Therapy: AFM and Fluorescence Imaging of Cisplatin Encapsulation, Stability, Cellular Uptake, and Toxicity. Langmuir 2006, 22 (19), 8156–8162.

    OpenUrlCrossRefPubMed
22. 22.↵
    1. Vorselen D.,
    2. MacKintosh F. C.,
    3. Roos W. H.,
    4. Wuite G. J. L.

    Competition between Bending and Internal Pressure Governs the Mechanics of Fluid Nanovesicles. ACS Nano 2017, 11 (3), 2628–2636.

    OpenUrl
23. 23.↵
    1. Folmsbee M.,
    2. Moussourakis M.

    Sterilizing Filtration of Liposome and Related Lipid-Containing Solutions: Enhancing Successful Filter Qualification. PDA J. Pharm. Sci. Technol. 2012, 66 (2), 161–167.

    OpenUrlAbstract/FREE Full Text
24. 24.↵
    1. Folmsbee M.

    Evaluation of the Effect of the Volume Throughput and Maximum Flux of Low Surface-Tension Fluids on Bacterial Penetration of 0.2 Micron Rated Filters during Process-Specific Filter Validation Testing. PDA J. Pharm. Sci. Technol. 2015, 69 (2), 307–316.

    OpenUrlAbstract/FREE Full Text
25. 25.↵
    Parenteral Drug Association Inc. PDA Technical Report No 26 (Revised 2008): Sterilizing Filtration of Liquids. PDA J. Pharm. Sci. Technol. 2008, 62 (S-5), 1–60.

    OpenUrlAbstract/FREE Full Text
26. 26.↵
    U.S. Food and Drug Administration, Guidance for Industry: Sterile Drug Products Produced by Aseptic Processing—Current Good Manufacturing Practice. Center for Biologics Evaluation and Research, U.S. Department of Health and Human Services: Rockville, MD, 2004.
27. 27.↵
    1. Singh B.,
    2. Mundlamuri R.,
    3. Friese T.,
    4. Mundrigi A.,
    5. Handt S.,
    6. Loewe T.

    Benchmarking of Sterilizing-Grade Filter Membranes with Liposome Filtration. PDA J. Pharm. Sci. Technol. 2018, 72 (3), 223–235.

    OpenUrlAbstract/FREE Full Text
28. 28.↵
    Microfluidics. How Our Microfluidizer Processors Work. Microfluidics Web site. https://www.microfluidics-mpt.com/microfluidics-technology/how-it-works (accessed March 31, 2020).
29. 29.↵
    1. Persson K. H.,
    2. Blute I. A.,
    3. Mira I. C.,
    4. Gustafsson J.

    Creation of Well-Defined Particle Stabilized Oil-in-Water Nanoemulsions. Colloids Surf., A 2014, 459, 48–57.

    OpenUrl
30. 30.↵
    1. Nguyen T. L.,
    2. Nguyen T. H.,
    3. Nguyen D. H.

    Development and In Vitro Evaluation of Liposomes Using Soy Lecithin to Encapsulate Paclitaxel. Int. J. Biomater. 2017, 2017, 8234712.

    OpenUrl
31. 31.↵
    1. Yuridian R.,
    2. Rosliana I.,
    3. Purwaningsih E. H.,
    4. Chaidir C.,
    5. Freisleben H.-J.,
    6. Pawitan J.

    Liposome Formulation of Soybean Phosphatidylcholine Extract from Argomulyo Variety Soy to Replace the Toxicity of Injectable Phosphatidylcholine Solution Containing Sodium Deoxycholate. Int. J. PharmTech Res. 2016, 9 (2), 166–175.

    OpenUrl
32. 32.↵
    1. Kulkarni S. B.,
    2. Betageri G. V.,
    3. Singh M.

    Factors Affecting Microencapsulation of Drugs in Liposomes. J. Microencapsulation 1995, 12 (3), 229–246.

    OpenUrlPubMed
33. 33.↵
    1. Elorza B.,
    2. Elorza M. A.,
    3. Sainz M. C.,
    4. Chantres J. R.

    Comparison of Particle Size and Encapsulation Parameters of Three Liposomal Preparations. J. Microencapsulation 1993, 10 (2), 237–248.

    OpenUrlPubMed
34. 34.↵
    1. Cagdas F. M.,
    2. Ertugral N.,
    3. Bucak S.,
    4. Atay N. Z.

    Effect of Preparation Method and Cholesterol on Drug Encapsulation Studies by Phospholipid Liposomes. Pharm. Dev. Technol. 2011, 16 (4), 408–414.

    OpenUrlPubMed
35. 35.↵
    1. Hermia J.

    Constant Pressure Blocking Filtration Laws—Application to Power-Law Non-Newtonian Fluids. Trans. Inst. Chem. Eng. 1982, 60 (3),183–187.

    OpenUrl
36. 36.↵
    1. Zydney A. L.,
    2. Ho C.-C.

    Scale-up of Microfiltration Systems: Fouling Phenomena and Vmax Analysis. Desalination 2002, 146 (1–3), 75–81.

    OpenUrl
37. 37.↵
    1. Badmington F.,
    2. Wilkins R.,
    3. Payne M.,
    4. Honig E. S.

    Vmax Testing for a Microfiltration Train Scale-Up in Biopharmaceutical Processing. Pharm. Technol. 1995, 19 (9), 64.

    OpenUrl
38. 38.↵
    1. Lujan H.,
    2. Griffin W. C.,
    3. Taube J. H.,
    4. Sayes C. M.

    Synthesis and Characterization of Nanometer-Sized Liposomes for Encapsulation and microRNA Transfer to Breast Cancer Cells. Int. J. Nanomed. 2019, 14, 5159–5173.

    OpenUrl
39. 39.↵
    1. Moghimi S. M.,
    2. Hunter A. C.,
    3. Murray J. C.

    Long-Circulating and Target Specific Nanoparticles: Theory to Practice. Pharmacol. Rev. 2001, 53 (2), 283–318.

    OpenUrlAbstract/FREE Full Text
40. 40.↵
    1. Danaei M.,
    2. Dehghankhold M.,
    3. Ataei S.,
    4. Hasanzadeh Davarani F.,
    5. Javanmard R.,
    6. Dokhani A.,
    7. Khorasani S.,
    8. Mozafari M. R.

    Impact of Particle Size and Polydispersity Index on the Clinical Applications of Lipidic Nanocarrier Systems. Pharmaceutics 2018, 10 (2), 57.

    OpenUrl
41. 41.↵
    1. Iritani E.,
    2. Katagiri N.,
    3. Inagaki G.

    Compression and Expansion Properties of Filter Cake Accompanied with Step Change in Applied Pressure in Membrane Filtration. Sep. Purif. Technol. 2018, 198, 3–9.

    OpenUrl
42. 42.↵
    1. Foley G.

    A Review of Factors Affecting Filter Cake Properties in Dead-End Microfiltration of Microbial Suspensions. J. Membr. Sci. 2006, 274 (1–2), 38–46.

    OpenUrl
43. 43.↵
    1. Morilla M. J.,
    2. Romero E. L.

    Ultradeformable Phospholipid Vesicles as a Drug Delivery System: A Review. Res. Reports Transdermal Drug Delivery 2015, 4, 55–69.

    OpenUrl
44. 44.↵
    1. Johnson J. M.,
    2. Ha T.,
    3. Chu S.,
    4. Boxer S. G.

    Early Steps of Supported Bilayer Formation Probed by Single Vesicle Fluorescence Assays. Biophys. J. 2002, 83 (6), 3371–3379.

    OpenUrlPubMedWeb of Science
45. 45.↵
    1. Schönherr H.,
    2. Johnson J. M.,
    3. Lenz P.,
    4. Frank C. W.,
    5. Boxer S. G.

    Vesicle Adsorption and Lipid Bilayer Formation on Glass Studied by Atomic Force Microscopy. Langmuir 2004, 20 (26), 11600–11606.

    OpenUrlCrossRefPubMedWeb of Science
46. 46.↵
    1. Richter R. P.,
    2. Bérat R.,
    3. Brisson A. R.

    Formation of Solid-Supported Lipid Bilayers: An Integrated View. Langmuir 2006, 22 (8), 3497–3505.

    OpenUrlCrossRefPubMedWeb of Science
47. 47.↵
    1. Reimhult E.,
    2. Zäch M.,
    3. Höök F.,
    4. Kasemo B.

    A Multitechnique Study of Liposome Adsorption on Au and Lipid Bilayer Formation on SiO2. Langmuir 2006, 22 (7), 3313–3319.

    OpenUrlPubMed
48. 48.↵
    1. Reimhult E.,
    2. Kasemo B.,
    3. Höök F.

    Rupture Pathway of Phosphatidylcholine Liposomes on Silicon Dioxide. Int. J. Mol. Sci. 2009, 10 (4), 1683–1696.

    OpenUrlPubMed
49. 49.↵
    1. Murrell M. P.,
    2. Voituriez R.,
    3. Joanny J.-F.,
    4. Nassoy P.,
    5. Sykes C.,
    6. Gardel M. L.

    Liposome Adhesion Generates Traction Stress. Nat. Phys. 2014, 10 (2), 163–169.

    OpenUrl